Amgen Inc.
AMGNNASDAQHealthcareDrug Manufacturers - General
As of Oct 22, 2026 close
- Market cap
- $243.32B
- P/E (TTM)
- 27.83
- Forward P/E
- 21.04
- Dividend yield
- 2.22%
- 52-week range
- $288.00$447.03
- Volume (live)
- -
- Avg. volume (3M)
- 2.95M
Amgen (AMGN) Stock Price & Financial Analysis
Amgen Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $437.19 - $450.98 |
|---|---|
| 52-Week High | $447.03 |
| 52-Week Low | $288.00 |
| Open | $441.55 |
| Volume (last close) | 3.10M |
| Average Volume (3M) | 2.95M |
| Revenue (TTM) | 38.09B |
|---|---|
| Net Income (TTM) | 8.74B |
| Free Cash Flow (TTM) | 10.18B |
| EPS (TTM) | $16.09 |
| Profit Margin | 22.95% |
| Operating Margin | 29.99% |
| Return on Equity (ROE) | 74.80% |
| Debt to Equity | 4.90 |
| Annual Dividend | $9.94 |
|---|---|
| Dividend Yield | 2.22% |
| Payout Ratio | 61.76% |
| Last Dividend Ex-Date | Aug 21, 2026 |
| Market Cap | 243.32B |
|---|---|
| Shares Outstanding | 544.00M |
| P/E Ratio (TTM) | 27.83 |
| Forward P/E | 21.04 |
| Price to Sales (P/S) | 6.39 |
| Price to Book (P/B) | 20.82 |
| EV/EBITDA | 17.42 |
| 50-Day MA | $415.73 |
|---|---|
| 200-Day MA | $369.94 |
| 1-Year Change | +52.71% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Amgen at a Glance
As of the Oct 22, 2026 close, Amgen (AMGN) has a market capitalization of $243.32B. The stock trades at 27.8× trailing earnings, 21.0× forward earnings and 6.4× sales. Over the trailing twelve months it earned $8.74B on revenue of $38.09B (a 22.9% profit margin) and generated $10.18B of free cash flow. Revenue grew 9.1% year over year.
As of its latest reported balance sheet, it holds $13.99B in cash and securities against $57.30B of debt, a net debt position of $43.31B.
Amgen pays a quarterly dividend totaling $9.94 per share a year, a 2.22% yield at the Oct 22, 2026 close, with a 62% payout ratio and 14 consecutive years of dividend increases.
The share price is up 52.7% over the past year. At $447.28 (the Oct 22, 2026 close) it sits near the top of its 52-week range of $288.00 to $447.03, above its 200-day moving average of $369.94.
Based on 33 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $403.33, 9.8% below the Oct 22, 2026 close.
Frequently Asked Questions About Amgen
What is the current stock price for AMGN?
As of the Oct 22, 2026 close, AMGN stock trades at $447.28. The 52-week range is $288.00–$447.03, with a day range of $437.19–$450.98.
What is the P/E ratio for AMGN?
As of the Oct 22, 2026 close, Amgen's trailing twelve-month (TTM) P/E ratio is 27.8, meaning investors pay $27.8 for every $1 of annual earnings. The forward P/E is 21.0, reflecting analyst expectations for future earnings. Amgen operates in the Healthcare sector.
Does AMGN pay dividends?
Yes, Amgen pays a 2.22% annual dividend yield as of the Oct 22, 2026 close ($9.94 per share a year). The trailing twelve-month payout ratio is 61.8%. The most recent ex-dividend date was August 21, 2026.
What do analysts recommend for AMGN?
Based on ratings from 33 professional analysts over the last 90 days, the consensus for AMGN is Hold. The average 12-month price target is $403.33, a 9.8% downside from the Oct 22, 2026 close of $447.28.
What is the market cap of AMGN?
As of the Oct 22, 2026 close, Amgen's market capitalization is $243.32B, classifying it as a mega-cap company. Amgen operates in the Healthcare sector within the Drug Manufacturers - General industry.